This invention relates to medical devices and methods for use in tissue characterization and treatment.
Techniques for in situ identifying abnormal (e.g. tumorous) cells in a biological tissue are generally known. Such techniques include those utilizing determination of the electrical properties of a tissue, for example, by determination of electrical impedance or dielectric constants. Some kinds of tumors can be identified by determining differences in the measured electrical properties of the tissue. The identified and located region of abnormal tissue can then be treated and/or removed from the body
Various types of tissue characterization sensor and its integration with a tissue treatment/removal tool are described in the following patent publications, all assigned to the assignee of the present application: US2003138378, WO2006103665, WO2007015255, U.S. Pat. No. 6,813,515 and U.S. Pat. No. 7,184,824.
Also, various techniques are known for removing a certain tissue specimen from a tissue mass. These techniques are disclosed for example in U.S. Pat. No. 6,689,145 and U.S. Pat. No. 7,122,011.
There is a need in the art to facilitate precise location and determination of a volume of a tissue specimen (e.g. abnormal tissues) to be treated (e.g. removed). Also, there is need in the art for a tissue treatment technique capable of adjusting a treatment volume to the determined volume of the abnormal tissue specimen.
The present invention solves the above problems by providing a novel medical device for use in tissue characterization and treatment. The device comprises a tissue characterization probe comprising an elongated carrier for carrying an array of tissue characterization sensors arranged in a spaced-apart relationship at least along an axis of said carrier. During the progression of the probe through a tissue mass, signals from the tissue characterization sensors are used for locating and determining a dimension of an abnormal tissue specimen inside the tissue mass. This enables consequent treatment of the abnormal tissue specimen by a treatment tool.
In preferred embodiment of the invention, the treatment tool is mounted on the characterization probe carrier. The treatment tool may be configured for carrying out at least one of the following biopsy, cutting, delivering physical treatment, delivering treatment medication, diagnostics.
Preferably, the treatment tool is selectively shiftable between its inoperative position being located substantially entirely inside the carrier and its operative position projecting by its at least one tissue treating portion towards outside the carrier. In preferred embodiments of the invention, the dimension of the tissue treating portion(s) projectable from the carrier, and possibly also location of the tissue treating portion(s) with respect to the carrier can be controllably varied.
In some embodiments of the invention, the probe carrier is formed with a guiding cutting tool, to facilitate insertion of the probe to a targeted location in the tissue. Also, in some embodiments of the invention, a marker may be left in the body, at the location of the treated (removed) tissue.
The invention also provides a novel method for use in tissue characterization and treatment. A tissue mass is scanned with an array of tissue characterization sensors arranged in a spaced-apart relationship along a scanning axis, and signals from the sensors are detected and analyzed while scanning locate and determine a dimension of an abnormal tissue specimen inside said tissue mass that is to be treated during progression of the array through the tissue mass.
Additionally, the invention provides a system for use in tissue characterization and treatment. The system comprises a medical device and a control unit connectable to the medical device. The latter is configured as described above, namely comprises a tissue characterization probe having a carrier on which an array of tissue characterization sensors is mounted with the sensors being arranged in a spaced-apart relationship at least along an elongated axis of the carrier. The control unit is configured for receiving and analyzing tissue characterizing signals from each of all the sensors and utilizing data indicative of the respective sensors' location, for determining a dimension of an abnormal tissue specimen.
In order to understand the invention and to see how it may be carried out in practice, embodiments will now be described, by way of non-limiting example only, with reference to the accompanying drawings, in which:
Referring to
The tissue characterization sensor array may include one or more of optical, radiofrequency (RF), microwave (MW), electrical, magnetic, temperature, elastic, biological, chemical, radioactive-emission, and mechanical sensors of any known type. The construction and operation of the tissue characterization sensor does not form part of the present invention, and therefore need not be specifically described. For example, sensors described in the above indicated patent publications assigned to the assignee of the present application may be used.
The sensors S1-S8 are arranged in a spaced-apart relationship along a longitudinal axis LA of the carrier 14, and may be arranged in one- or two dimensional array. For example, the sensor array may include, in addition to a group of sensors arranged in one-dimensional array, sensors arranged in a spaced-apart manner along a circumferential region of the carrier. The sensor array gives, in real time, indication about the nature of tissue along the carrier 14.
The sensors are spaced along the axis LA from one another a known distance, which may or may not be equal for all the sensors in the array. The known relative locations of the sensors along the carrier 12 allows for identifying corresponding locations in a tissue mass when the probe is progressing through the tissue mass (i.e. scans the tissue) based on signals received from the sensors. In this connection, the medical device 10 is associated with an appropriate control system 19 configured for receiving and analyzing the signals generated by the sensors. It should be understood that connection between the sensors and the control unit is shown in the figure schematically, and in case wired connection is used such wires would extend inside the shaft 14 and exit at the proximal end 14B.
The control system may be an external system connectable (via wires or wireless signal transmission) to the sensors, or may be a constructional part of the probe itself. The control system, based on the analysis of the received signals, operates for determining a location of the margins of an abnormal tissue region inside the examined tissue mass and generating output data indicative of a dimension of the abnormal tissue region. This allows for consequent treatment of the abnormal tissue region by an appropriate treatment tool.
The control system preferably includes a graphical user interface (GUI) 19A, and is configured for presenting information related to the signals received from each of the sensors. This information provides the operator with information regarding the tissue type at the locations of the sensors. The information presented on the GUI may assist the operator in analyzing the location and extent of the tissue to be treated.
Generally, the treatment tool may be configured for carrying out one or more of the following: biopsy, cutting, delivering physical treatment, delivering treatment medication, diagnostics. More specifically, the present invention is used for removal of an intact tissue specimen (abnormal tissue) and is therefore described below with respect to this specific but not limiting example.
Preferably, the probe 12 also carries a treatment tool, e.g. a cutting tool. This is implemented by configuring the probe such that the treatment tool can be selectively shiftable between its inoperative position, when it is located substantially entirely inside the carrier 14, and its operative positions when its one or more excision elements (constituting one or more tissue treating elements) project(s) from the carrier.
In some examples of the invention, the selective projection of the excision element is achieved by using the treatment tool of a kind known in the art, where the excision element projects from the carrier body through an opening made along the body portion while moving with respect to the carrier along an axis inclines with respect to the axis LA. In some other examples, the excision element projects from the carrier (e.g. from its distal end) while moving with respect to the carrier substantially along the axis LA. Such configurations are also generally known in the art. The treatment tool may be configured with a removed tissue collecting unit, which may or may not be selectively projectable from the probe.
According to the invention, the medical device is configured such that a dimension of the excision element part projecting from the carrier can be controllably adjusted (varied) in accordance with the determined dimension of the abnormal tissue margins, thereby adjusting the excision volume. Preferably, the excision element is configured for both cutting the tissue and collecting the tissue being cut.
The following are some specific but not limiting examples of the configuration of the device of the present invention. The same reference numbers are used for identifying components that are common in all the examples.
The cutting tool 16 has a body portion 22 located inside the carrier 14, and an excision element 20 projectable from the body 22 through an opening 18 made in the carrier 14 In the figure, the excision element 20 is shown in its operative projecting state. The excision element has a cutting edge 21, and may be configured to have a cup-like shape when in the projecting state, thereby enabling collection of tissue while being cut during the rotation of the carrier 14 and thus of the excision element 20.
The excision element 20 extends between its first and second ends 20A and 20B which are attached to respective first and second locations on the treatment tool body 22 and spaced-apart along the axis LA of the carrier 14. The treatment tool is configured to enable a controllable change of the dimensions of the excision element 20. In the present example, this is implemented by making the treatment tool body 22 from two spaced members 22A and 22B, where at least one of them is slidable with respect to the other along the carrier axis LA. As a result, a distance between the first and second locations, and accordingly the first and second ends 20A and 20B of the excision element, changes, thereby enable adjustment of the dimension of the cutting portion 21 projecting through the carrier 14.
By controlling the location of the excision element distal and proximal ends 20A and 20B along the carrier 14, and thus controlling the excision volume, a user can perform optimal removal of a tissue specimen, for example during a breast biopsy procedure. The entire excision element 20 may be movable along the body 22. Thus, the excision volume is controlled by user by changing the location of the excision element 20 along the carrier 14 and changing a distance between the distal and proximal ends of the excision element.
In the above example, the tissue removal procedure is carried while rotating the carrier 14. Such procedure can be performed while keeping the carrier position and rotating the treatment tool. This is exemplified in
It should be understood that in all the above-exemplified embodiments the device may be rotated, manually or mechanically, to assist in completer tissue treatment (e.g. cutting and removal).
Thus, the present invention provides a novel medical device capable of precisely located a tissue volume to be treated (removed), and also provides for treating (removing) the tissue by an integral medical device.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IL2008/000965 | 7/13/2008 | WO | 00 | 12/10/2009 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2009/010960 | 1/22/2009 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
5846513 | Carroll et al. | Dec 1998 | A |
6006755 | Edwards | Dec 1999 | A |
6120437 | Yoon et al. | Sep 2000 | A |
6321109 | Ben-Haim et al. | Nov 2001 | B2 |
6331166 | Burbank et al. | Dec 2001 | B1 |
6419635 | Hedengren et al. | Jul 2002 | B1 |
6419640 | Taylor | Jul 2002 | B1 |
6440147 | Lee et al. | Aug 2002 | B1 |
6689145 | Lee et al. | Feb 2004 | B2 |
6813515 | Hashimshony | Nov 2004 | B2 |
7122011 | Clifford et al. | Oct 2006 | B2 |
7184824 | Hashimshony | Feb 2007 | B2 |
8413582 | Chen | Apr 2013 | B1 |
20010047169 | McGuckin, Jr. et al. | Nov 2001 | A1 |
20020019597 | Dubrul et al. | Feb 2002 | A1 |
20020035361 | Houser et al. | Mar 2002 | A1 |
20030009110 | Tu et al. | Jan 2003 | A1 |
20030050574 | Krueger | Mar 2003 | A1 |
20030055423 | Levinson | Mar 2003 | A1 |
20030138378 | Hashimshony | Jul 2003 | A1 |
20040255739 | Clifford et al. | Dec 2004 | A1 |
20050203419 | Ramanujam et al. | Sep 2005 | A1 |
20100168611 | Hashimshony et al. | Jul 2010 | A1 |
20130177972 | Green et al. | Jul 2013 | A1 |
Number | Date | Country |
---|---|---|
9217108 | Oct 1992 | WO |
WO 9812968 | Apr 1998 | WO |
WO 9944506 | Sep 1999 | WO |
0174252 | Oct 2001 | WO |
2006103665 | Oct 2006 | WO |
2007015255 | Feb 2007 | WO |
2007083310 | Jul 2007 | WO |
WO 2011016035 | Feb 2011 | WO |
WO 0182998 | Nov 2011 | WO |
Entry |
---|
Office Action issued by the European Patent Office dated Nov. 25, 2011 in Application No. 08 776 603.6. |
Jan. 24, 2013 Search Report issued in EP Application No. 12168882.4. |
International Search Report and Written Opinion dated Mar. 23, 2009 in corresponding International Application No. PCT/IL2008/000965. |
Number | Date | Country | |
---|---|---|---|
20100168611 A1 | Jul 2010 | US |